Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-09-12
DOI
10.3389/fimmu.2018.02060
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influenza vaccines: ‘tailor-made’ or ‘one fits all’
- (2018) Giulietta Saletti et al. CURRENT OPINION IN IMMUNOLOGY
- Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery
- (2018) Luigi Battaglia et al. Expert Opinion on Drug Delivery
- Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination
- (2018) Lei Zhang et al. International Journal of Nanomedicine
- Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
- (2018) Young-Tae Lee et al. PLoS One
- Towards a universal influenza vaccine: different approaches for one goal
- (2018) Giuseppe A. Sautto et al. Virology Journal
- Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses
- (2018) Lei Deng et al. Nature Communications
- IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission
- (2018) Jonas Klinkhammer et al. eLife
- Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
- (2018) Santosh Dhakal et al. Frontiers in Immunology
- Nasal nanovaccines
- (2017) B. Bernocchi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection
- (2017) D G Eliasson et al. Mucosal Immunology
- Influenza A virus vaccines for swine
- (2017) Amy L. Vincent et al. VETERINARY MICROBIOLOGY
- Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre
- (2017) Victoria M. W. Gould et al. Frontiers in Microbiology
- Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice
- (2017) Yu-Jin Kim et al. Frontiers in Immunology
- A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
- (2017) Raffael Nachbagauer et al. npj Vaccines
- M2-based influenza vaccines: recent advances and clinical potential
- (2016) Annasaheb Kolpe et al. Expert Review of Vaccines
- Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles
- (2016) B. Bernocchi et al. JOURNAL OF CONTROLLED RELEASE
- Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination
- (2016) Mai-Chi Trieu et al. JOURNAL OF INFECTIOUS DISEASES
- Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model
- (2016) Beth C. Holbrook et al. VACCINE
- Universal influenza vaccines: Shifting to better vaccines
- (2016) Francesco Berlanda Scorza et al. VACCINE
- Mucosal Vaccine Development Based on Liposome Technology
- (2016) Valentina Bernasconi et al. Journal of Immunology Research
- How Follicular Dendritic Cells Shape the B-Cell Antigenome
- (2016) Jan Kranich et al. Frontiers in Immunology
- Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs
- (2016) Jagadish Hiremath et al. PLoS One
- Overcoming the Diffusion Barrier of Mucus and Absorption Barrier of Epithelium by Self-Assembled Nanoparticles for Oral Delivery of Insulin
- (2015) Wei Shan et al. ACS Nano
- Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection
- (2015) Isabelle Dimier-Poisson et al. BIOMATERIALS
- Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity
- (2015) Jaina M. Patel et al. BIOTECHNOLOGY AND BIOENGINEERING
- Influenza Vaccines: Challenges and Solutions
- (2015) Katherine Houser et al. Cell Host & Microbe
- Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production
- (2015) Sean R. McMaster et al. JOURNAL OF IMMUNOLOGY
- Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates
- (2015) Jong R. Kim et al. JOURNAL OF VIROLOGY
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
- (2015) Hadi M Yassine et al. NATURE MEDICINE
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
- (2015) A. Impagliazzo et al. SCIENCE
- Influenza virus activation of the interferon system
- (2015) Marian J. Killip et al. VIRUS RESEARCH
- Animal models for influenza virus pathogenesis, transmission, and immunology
- (2014) Rajagowthamee R. Thangavel et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus
- (2014) D. M. Carragher et al. JOURNAL OF IMMUNOLOGY
- Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects
- (2014) Sutapa Barua et al. Nano Today
- Protective Immunity Based on the Conserved Hemagglutinin Stalk Domain and Its Prospects for Universal Influenza Vaccine Development
- (2014) Madhu Khanna et al. Biomed Research International
- Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
- (2013) Chompoonuch Sawaengsak et al. AAPS PHARMSCITECH
- Biomimetic Antigenic Nanoparticles Elicit Controlled Protective Immune Response to Influenza
- (2013) Dustin P. Patterson et al. ACS Nano
- Broadly neutralizing antibodies against influenza viruses
- (2013) Nick S. Laursen et al. ANTIVIRAL RESEARCH
- Dysregulation in lung immunity - The protective and pathologic Th17 response in infection
- (2013) Emily E. Way et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Development of universal influenza vaccines based on influenza virus M and NP genes
- (2013) M. Zheng et al. INFECTION
- Lung-resident memory CD8 T cells (TRM ) are indispensable for optimal cross-protection against pulmonary virus infection
- (2013) Tao Wu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A Novel Subnucleocapsid Nanoplatform for Mucosal Vaccination against Influenza Virus That Targets the Ectodomain of Matrix Protein 2
- (2013) P.-L. Herve et al. JOURNAL OF VIROLOGY
- Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques
- (2013) Yannick Vanloubbeeck et al. VACCINE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune Modulators
- (2013) Christophe Barnier-Quer et al. Pharmaceutics
- Mucosal Vaccine Design and Delivery
- (2012) Kim A. Woodrow et al. Annual Review of Biomedical Engineering
- Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells
- (2012) Christophe Dombu et al. BIOMATERIALS
- High Titer and Avidity of Nonneutralizing Antibodies against Influenza Vaccine Antigen Are Associated with Severe Influenza
- (2012) Kelvin K. W. To et al. Clinical and Vaccine Immunology
- Mucosal immunity and nasal influenza vaccination
- (2012) Markus A Rose et al. Expert Review of Vaccines
- Mucosal IgA responses in influenza virus infections; thoughts for vaccine design
- (2012) Elly van Riet et al. VACCINE
- Complement Activation and Complement Receptors on Follicular Dendritic Cells Are Critical for the Function of a Targeted Adjuvant
- (2011) J. Mattsson et al. JOURNAL OF IMMUNOLOGY
- The DBA.2 Mouse Is Susceptible to Disease following Infection with a Broad, but Limited, Range of Influenza A and B Viruses
- (2011) N. Pica et al. JOURNAL OF VIROLOGY
- T cell responses during influenza infection: getting and keeping control
- (2011) Taeg S. Kim et al. TRENDS IN IMMUNOLOGY
- A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus
- (2011) Dubravka Grdic Eliasson et al. VACCINE
- A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity
- (2011) Orli Even-Or et al. VACCINE
- Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types
- (2010) Ting Zhang et al. VACCINE
- Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen
- (2009) Malou Henriksen-Lacey et al. JOURNAL OF CONTROLLED RELEASE
- Critical Role of IL-17RA in Immunopathology of Influenza Infection
- (2009) C. R. Crowe et al. JOURNAL OF IMMUNOLOGY
- Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally
- (2009) Yuri Ghendon et al. JOURNAL OF MEDICAL VIROLOGY
- Positively-Charged, Porous, Polysaccharide Nanoparticles Loaded with Anionic Molecules Behave as ‘Stealth’ Cationic Nanocarriers
- (2009) Archibald Paillard et al. PHARMACEUTICAL RESEARCH
- Nanoparticles for nasal vaccination
- (2008) Noemi Csaba et al. ADVANCED DRUG DELIVERY REVIEWS
- Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice
- (2008) Masanori Isaka et al. MICROBIOLOGY AND IMMUNOLOGY
- Follicular dendritic cell networks of primary follicles and germinal centers: Phenotype and function
- (2008) Christopher D.C. Allen et al. SEMINARS IN IMMUNOLOGY
- Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model
- (2008) Niels Hagenaars et al. VACCINE
- CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine
- (2008) Dubravka Grdic Eliasson et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation